Executives On The Move: Changes At Albireo Pharma, AbbVie And Lundbeck
Executive Summary
Recent executive moves in the industry include C-suite changes at Albireo Pharma, Aptevo Therapeutics and AbbVie. Meanwhile, new directors were appointed at Amarin and Oculis Holding.
You may also be interested in...
Pipeline Watch: Eight Approvals And 12 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: UCB, LAVA Therapeutics and More
Recent executive moves in the industry include C-suite changes at Arcus Biosciences and UCB. Meanwhile, new directors were appointed at Arovella Therapeutics and LAVA Therapeutics.
Pipeline Watch: ACC Meeting Dominates Clinical Updates Plus Four New Approvals
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.